Skip to main content
Equibles
OWLT logo

OWLT · Owlet, Inc. · Metrics

Track OWLT — free

Use OWLT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$4.86 -0.12 (-2.41%)
Rebalance outlook locked
Going-concern doubt — cleared Aug 14, 2026

The latest filing states the doubt was alleviated.

“In accordance with ASU No. 2014-15, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern (Subtopic 205-40), the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the unaudited condensed consolidated financial statements included in this quarterly report on Form 10-Q are issued.”
View the 10-Q filed Aug 14, 2026
Market Cap
$142.02M
Shares
29.22M

OWLT metrics

69 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$4.98
Market cap
$142.02M

Price action

20 metrics
Price change (1W)
-0.2%
Price change (30D)
-8.1%
Price change (3M)
+6.6%
Price change (6M)
-31.4%
Price change (YTD)
-69.2%
Price change (1Y)
-31.8%
Trailing year
Price change (5Y)
—
52-week high
$16.52
52-week low
$4.44
Change from 52-week high
-69.9%
Change from 52-week low
+12.2%
Annualized volatility
82.1%
Annualized volatility (3M)
63.4%
Beta
2.3
RSI (14D)
41.2
Price vs SMA 50
-10.0%
Price vs SMA 200
-39.6%
Avg volume (3M)
208,496
Relative volume
0.6
Average dollar volume
$1.12M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
29.22M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
1.1×
reciprocal yield 87.3%
EV / EBITDA
—
EV / EBIT
—
P / sales
1.3×
reciprocal yield 78.9%
P / book
6.3
reciprocal yield 15.9%
FCF yield
-5.9%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-6.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.1×
reciprocal yield 89.7%
EV / revenue historical average (5Y)
1.4×
reciprocal yield 70.9%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-11

Profitability

9 metrics
Gross margin
54.8%
Operating margin
-6.3%
Trailing 12 months
Net margin
-7.7%
Gross profit (TTM)
$62.89M
Operating profit (TTM)
−$7.23M
Net income (TTM)
−$8.81M
Trailing 12 months
Diluted EPS (TTM)
$-0.35
FCF margin
-7.4%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-1.93

Growth

11 metrics
Revenue growth YoY
+29.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$114.86M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+81.4%
Year over year · more shares
Revenue CAGR (3Y)
+15.3%
Revenue CAGR (5Y)
+7.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-38.1%
Return on assets
-9.4%
Debt / equity
0.7
Current ratio
1.6
EBITDA (TTM)
−$6.54M
Free cash flow (TTM)
−$8.53M
Quick ratio
1.3
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$13.88M
Latest balance sheet
Cash & equivalents
$30.95M
Total assets
$93.57M
Total debt
$17.06M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$7.76M
Capital expenditures (TTM)
$762,000
R&D (TTM)
$15.87M
SG&A (TTM)
—
Stock compensation (TTM)
$12.94M
R&D / revenue
13.8%
Stock compensation / revenue
11.3%

Ownership (13F)

3 metrics
13F filers
59
13F filer change QoQ
-8
Institutional ownership
58.5%

Short interest

3 metrics
Short interest
1.7%
Latest settlement · 2.0 days to cover
Days to cover
2.0d
Short-squeeze score
44 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1816708 CUSIP 69120X206 13F (30d) 44 filings 44 filers Visit website Investor relations